TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 47 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2015 | $611,000 | -23.1% | 4,335 | -19.2% | 0.06% | +37.5% |
| Q4 2014 | $795,000 | -24.4% | 5,363 | -21.6% | 0.04% | -24.5% |
| Q3 2014 | $1,052,000 | +36.4% | 6,840 | +24.4% | 0.05% | +51.4% |
| Q2 2014 | $771,000 | -31.7% | 5,499 | -45.9% | 0.04% | -34.0% |
| Q1 2014 | $1,129,000 | -36.4% | 10,172 | -43.3% | 0.05% | -33.8% |
| Q4 2013 | $1,774,000 | +28.3% | 17,933 | -1.4% | 0.08% | +95.1% |
| Q3 2013 | $1,383,000 | +36.1% | 18,195 | +0.1% | 0.04% | -14.6% |
| Q2 2013 | $1,016,000 | -4.6% | 18,181 | +0.2% | 0.05% | -2.0% |
| Q1 2013 | $1,065,000 | +23.1% | 18,142 | +1.7% | 0.05% | +14.0% |
| Q4 2012 | $865,000 | +5.7% | 17,838 | -0.4% | 0.04% | +10.3% |
| Q3 2012 | $818,000 | – | 17,907 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 85,205 | $9,416,000 | 7.01% |
| FORT, L.P. | 149,014 | $16,468,000 | 5.67% |
| Strategic Global Advisors, LLC | 80,231 | $11,336,000 | 4.23% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 701,900 | $77,567,000 | 3.19% |
| Ativo Capital Management LLC | 78,727 | $8,700,000 | 2.01% |
| Analyst IMS Investment Management Services Ltd. | 31,438 | $3,474,000 | 1.47% |
| Parametrica Management Ltd | 4,327 | $478,000 | 1.32% |
| Freestone Capital Holdings, LLC | 89,005 | $9,836,000 | 0.90% |
| RPG Investment Advisory, LLC | 19,580 | $2,163,000 | 0.68% |
| MERITAGE PORTFOLIO MANAGEMENT | 38,465 | $4,251,000 | 0.47% |